• Profile
Close

Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy

Head & Neck Aug 16, 2018

Hegde JV, et al. - Using high-dose-rate (HDR) brachytherapy in head and neck cancer reirradiation, experts report on their experience regarding the preferential sparing of normal anatomic structures surrounding the radiation target. An excellent local control and encouraging overall survival (OS) could be provided by curative-intent HDR brachytherapy reirradiation. In view of the late toxicity rates, patient selection is vital, since treatment is especially useful for younger patients or those treated with salvage resection. Palliatively, 65% demonstrated a 6-month local control. Findings suggested an association of age >70 years with poorer OS. Prior salvage resection showed a trend toward improved local control and OS.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay